INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 45h ago
House PTR5h ago
SEC 13F5h ago
Robinhood Chain5h ago

Results

8,830 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
39
PJ
Pitofsky JasonSVP Controller
REGNREGENERON PHARMACEUTICALS, INC.
Open-market sale
SELL$925K
982 sh
Nov 4, 2026Nov 6, 2026
Page 3 of 221
← PrevNext →
traded Nov 4, 2026
+2d
SEC Form 4

Evidence

39
JL
Jordan Rhonda LDirector
ESABESAB Corp
Open-market sale
SELL$294K
3,733 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

39
WJ
White Matthew JChief Financial Officer
LINLINDE PLC
Open-market sale
SELL$8.22M
15.7K sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

39
HN
Hunn Laurence NeilDirector, President and CEO
ROPROPER TECHNOLOGIES INC
Open-market sale
SELL$1.54M
3,120 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

39
HN
Hunn Laurence NeilDirector, President and CEO
ROPROPER TECHNOLOGIES INC
Open-market sale
SELL$2.16M
4,366 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

39
HN
Hunn Laurence NeilDirector, President and CEO
ROPROPER TECHNOLOGIES INC
Open-market sale
SELL$4.77M
9,690 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

39
SC
Seidman Becker CarynDirector, Chief Executive Officer, 10% Owner
YOUClear Secure, Inc.
Open-market sale · 10b5-1 plan
SELL$10.00M
165.4K sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

38
BA
Baker Bros. Advisors LpDirector
MDGLMADRIGAL PHARMACEUTICALS, INC.
Open-market purchase
BUY$2.05M
5,586 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

38
BA
Baker Bros. Advisors LpDirector
MDGLMADRIGAL PHARMACEUTICALS, INC.
Open-market purchase
BUY$3.71M
10.1K sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

37
BA
Baker Bros. Advisors LpDirector
MDGLMADRIGAL PHARMACEUTICALS, INC.
Open-market purchase
BUY$23.13M
60.4K sh
Nov 6, 2026Nov 6, 2026
traded Nov 6, 2026
+0dSEC Form 4

Evidence

37
CA
Capuano AnthonyDirector, President & CEO
MARMARRIOTT INTERNATIONAL INC /MD/
Open-market sale
SELL$542K
1,288 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

37
LJ
Little Harrison JamesExecutive Vice President
KYNKayne Anderson Energy Infrastructure Fund, Inc.
Open-market purchase
BUY$52K
3,900 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

37
RH
Reiss Rena HozoreEVP & General Counsel
MARMARRIOTT INTERNATIONAL INC /MD/
Open-market sale
SELL$870K
2,056 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

37
Wilhelmsen Arne AlexanderDirector
RCLROYAL CARIBBEAN CRUISES LTD
Open-market sale
SELL$632K
1,974 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

37
Wilhelmsen Arne AlexanderDirector
RCLROYAL CARIBBEAN CRUISES LTD
Open-market sale
SELL$444K
1,355 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

37
Wilhelmsen Arne AlexanderDirector
RCLROYAL CARIBBEAN CRUISES LTD
Open-market sale
SELL$469K
1,470 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

36
HK
Hillesland KevinSVP, Structured Finance
GATXGATX CORP
Open-market sale
SELL$262K
1,400 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

36
LR
Lavu RatnakarEVP & Chief Digital Info Ofr
ELVElevance Health, Inc.
Open-market sale
SELL$572K
1,300 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

36
BL
Benitez Jorge L.Director
WKCWORLD KINECT CORP
Open-market sale
SELL$475K
13.0K sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

36
RA
Rey David ADirector
FICOFAIR ISAAC CORP
Open-market sale
SELL$12K
8 sh
Sep 15, 2025Nov 6, 2026
traded Sep 15, 2025
+417dSEC Form 4

Evidence

35
WU
Workers United10% Owner
AMALAmalgamated Financial Corp.
Open-market sale
SELL$4.72M
92.8K sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

35
WU
Western States Regional Joint Board, Workers United10% Owner
AMALAmalgamated Financial Corp.
Open-market sale
SELL$4.72M
92.8K sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

35
MN
Massey Richard NDirector
ALITAlight, Inc. / Delaware
Open-market sale
SELL$303K
25.0K sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

35
BA
Baker Bros. Advisors LpDirector, 10% Owner
KODKodiak Sciences Inc.
Open-market purchase
BUY$861K
8,742 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

35
FM
Foster Jon MEVP and COO
HCAHCA Healthcare, Inc.
Open-market sale
SELL$1.33M
2,692 sh
Nov 6, 2026Nov 6, 2026
traded Nov 6, 2026
+0dSEC Form 4

Evidence

35
SP
Strommer Richard PaulChief Actuary
GLREGREENLIGHT CAPITAL RE, LTD.
Open-market sale
SELL$410K
25.0K sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

35
PW
Pollard Charles W.Director
ALGTAllegiant Travel CO
Open-market sale
SELL$930K
10.0K sh
Nov 6, 2026Nov 6, 2026
traded Nov 6, 2026
+0dSEC Form 4

Evidence

34
BA
Baker Bros. Advisors LpDirector
MDGLMADRIGAL PHARMACEUTICALS, INC.
Open-market purchase
BUY$5.34M
13.7K sh
Nov 6, 2026Nov 6, 2026
traded Nov 6, 2026
+0dSEC Form 4

Evidence

34
FM
Foulkes David MChief Executive Officer
BCBRUNSWICK CORP
Open-market sale
SELL$3.80M
48.1K sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

34
Wilhelmsen Arne AlexanderDirector
RCLROYAL CARIBBEAN CRUISES LTD
Open-market sale
SELL$215K
659 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

34
JJ
Jackson JamereCFO
AZOAUTOZONE INC
Open-market sale
SELL$1.06M
320 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

34
BA
Baker Bros. Advisors LpDirector, 10% Owner
KODKodiak Sciences Inc.
Open-market purchase
BUY$8.05M
81.7K sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

34
KN
Klein Gal NirDirector, VP Marketing & Israel Sales
SYNXSilynxcom Ltd.
Open-market purchase
BUY$9,900
9,940 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

34
JJ
Jackson JamereCFO
AZOAUTOZONE INC
Open-market sale
SELL$2.43M
730 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

34
JJ
Jackson JamereCFO
AZOAUTOZONE INC
Open-market sale
SELL$2.19M
662 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

34
JJ
Jackson JamereCFO
AZOAUTOZONE INC
Open-market sale
SELL$1.38M
417 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

33
BA
Bonarti Michael ACorporate Vice President
ADPAUTOMATIC DATA PROCESSING INC
Open-market sale · 10b5-1 plan
SELL$2.11M
6,812 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

33
FC
Flynn Sean C.Chief Legal Officer
VCELVericel Corp
Open-market sale · 10b5-1 plan
SELL$779K
15.0K sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

33
GC
Goldberg ChenEVP, Product & Engineering
CRWVCoreWeave, Inc.
Open-market sale
SELL$893K
19.2K sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

33
ER
Epstein David RDirector
AGMBAgomAb Therapeutics NV
Open-market purchase
BUY$34K
5,000 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence